Cytokinetics Stock Skyrockets on Positive Results from Study of Its Heart Drug - Investopedia
investopedia.comSubmitted by investopedia8786 in business
Cytokinetics Inc. reported positive results Wednesday from a key Phase 3 study of its experimental drug to treat heart disease.